These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8530804)

  • 1. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.
    Jilg W; Sieger E; Zachoval R; Schätzl H
    J Hepatol; 1995 Jul; 23(1):14-20. PubMed ID: 8530804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.
    Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Filippini P; Piccinino F
    J Med Virol; 2001 Jul; 64(3):350-5. PubMed ID: 11424125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection.
    Sato S; Fujiyama S; Tanaka M; Yamasaki K; Kuramoto I; Kawano S; Sato T; Mizuno K; Nonaka S
    J Hepatol; 1994 Aug; 21(2):159-66. PubMed ID: 7527435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
    Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
    Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction.
    Inokuchi K; Nakata K; Hamasaki K; Daikoku M; Nakao K; Kato Y; Yatsuhashi H; Koga M; Yano M; Nagataki S
    J Hepatol; 1996 Mar; 24(3):258-64. PubMed ID: 8778190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors.
    Ramia S; Ramlawi F; Kanaan M; Klayme S; Naman R
    Epidemiol Infect; 2005 Aug; 133(4):695-9. PubMed ID: 16050516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen.
    Luo KX; Zhou R; He C; Liang ZS; Jiang SB
    J Med Virol; 1991 Sep; 35(1):55-9. PubMed ID: 1940884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen.
    Berger A; Doerr HW; Rabenau HF; Weber B
    Intervirology; 2000; 43(2):71-6. PubMed ID: 10971123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion rate to positivity for antibodies against core antigen of hepatitis B virus and duration of renal replacement therapy.
    Grzegorzewska AE; Kaczmarek-Leki V; Młot-Michalska M; Niepolski L
    Nephrol Dial Transplant; 2011 Mar; 26(3):970-6. PubMed ID: 20732926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication.
    Wedemeyer H; Cornberg M; Tegtmeyer B; Frank H; Tillmann HL; Manns MP
    Clin Microbiol Infect; 2004 Jan; 10(1):70-2. PubMed ID: 14706089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of blood-borne viral infections in Afghanistan.
    Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM
    Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance.
    Knöll A; Hartmann A; Hamoshi H; Weislmaier K; Jilg W
    World J Gastroenterol; 2006 Feb; 12(8):1255-60. PubMed ID: 16534880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes.
    Sengler U; Reinhard T; Adams O; Gerlich W; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):783-7. PubMed ID: 11760041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
    PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens.
    Heimer R; Khoshnood K; Jariwala-Freeman B; Duncan B; Harima Y
    J Infect Dis; 1996 Apr; 173(4):997-1000. PubMed ID: 8603983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.